)
)
Cyclacel Pharmaceuticals Inc Investor Relations Material
Latest events
Q2 2024
Cyclacel Pharmaceuticals Inc
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Cyclacel Pharmaceuticals Inc
Access all reports
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing cancer therapies. The company's research and development efforts target the regulation of the cell cycle, aiming to treat cancers and other serious diseases that result from abnormal cell division. Cyclacel's pipeline includes small-molecule drugs designed to inhibit specific enzymes and proteins involved in cancer cell growth and survival. The company's therapeutic candidates are being developed for a range of oncology applications, with the goal of addressing unmet medical needs in cancer treatment. The company is headquartered in Berkeley Heights, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
CYCC
Country
🇺🇸 United States